Additive effects of infection and neutropenia on the induction of granulocytopoietic activity in vivo

Cancer

Volumn 86, Issue 2, 1999, Pages 340-348

  Bönig, Halvard B ^a   Hannen, Martin ^a   Lex, Christiane ^a   Wölfel, Sonja ^a   Banning, Ursula ^a   Nürnberger, Wenzel ^a   Körholz, Dieter ^a   Göbel, Ulrich ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

G CSF; Growth factor; IL 11; Infection; Neutropenia; SCF

Indexed keywords

AMSACRINE; ASPARAGINASE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; METHOTREXATE; MITOXANTRONE; STEM CELL FACTOR; TENIPOSIDE; VINCRISTINE;

ADOLESCENT; ADULT; AGE; APLASIA; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; COMORBIDITY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG BLOOD LEVEL; GRANULOCYTE FUNCTION; GRANULOPOIESIS; HUMAN; INFANT; INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; NEUTROPENIA; PRIORITY JOURNAL;

EID: 17444452096     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990715)86:2<340::AID-CNCR19>3.3.CO;2-Q     Document Type: Article

References (37)

1. Burdach SEG, Müschenich M, Josephs W, Frisch H, Schulz G, Jürgens H, et al. Granulocyte-macrophage-colony stimulating factor for prevention of neutropenia and infection in children and adolescents with solid tumors. Cancer 1995;76: 510-6.
2. Lindemann A, Herrmann F, Oster W, Haffner G, Meysenburg W, Souza LM, et al. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 1989;74:2644-51.
3. Nathan CF. Respiratory burst in adherent human neutrophils: triggering by colony-stimulating factors CSF-GM and CSF-G. Blood 1989;73:301-6.
4. Weite K, Reiter A, Mempel K, Pretsch M, Schwab G, Schrappe M, et al. A randomized phase-III study of the efficacy of gianulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Blood 1996;87: 3143-50.
5. Kawada H, Sassao T, Yonekura S, Hotta T. Clinical significance of granulocyte colony-stimulating factor (G-CSF) receptor expression in acute myeloid leukemia. Leuk Res 1998; 22:31-7.
6. Sperling C, Schwartz S, Buchner T, Thiel E, Ludwig WD. Expression of the stem cell factor receptor C-KIT (CD117) in acute leukemias. Haematologica 1997;82:617-21.
7. Liang DC, Chen SH, Lean SF. Role of granulocyte colony-stimulating factor as adjunct therapy for septicemia in children with acute leukemia. Am J Hematol 1995;48:76-81.
8. Aviles A, Guzman R, Garcia EL, Talalvera A, Diaz-Maqueo JC. Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopenia. Anticancer Drugs 1996;7:392-7.
9. Takeyama H, Yamada H, Emi N, Saito H, Takeshita A, Ohno T, et al. Efficacy of early administration of G-CSF after intensive chemotherapy in acute leukemia: a randomized controlled trial. Tokai Infection Study Group on Hematological Disorders. Rinsho Ketsueki 1995;36:1257-65.
10. Kawakami M, Tsutsumi H, Kumakawa T, Abe H, Hirai M, Kurosawa S, et al. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 1990;76: 1962-4.
11. Reisbach G, Kamp T, Welzl G, Giez C, Abedinpour F, Lodri A, et al. Regulated plasma levels of colony-stimulating factors, interleukin-6 and interleukin-10 in patients with acute leukaemia and non-Hodgkin's lymphoma undergoing cytoreductive chemotherapy. Br J Haematol 1996;92:907-12.
12. Cebon J, Layton JE, Maher D, Morstyn G. Endogenous haemopoietic growth factors in neutropenia and infection. Br J Haematol 1994;86:265-74.
13. Lai CF, Baumann H. Interleukin-1 beta induces production of granulocyte colony-stimulating factor in human hepatoma cells. Blood 1996;87:4143-8.
14. Lenhoff S, Sallerfors B, Olofsson T. IL-10 as an autocrine regulator of CSF secretion by monocytes: disparate effects on GM-CSF and G-CSF secretion. Exp Hematol 1998;26:299-304.
15. Vellenga E, Dokter W, de Wolf JT, van de Vinne B, Esselink MT, Halie MR. Interleukin-4 prevents the induction of G-CSF mRNA in human adherent monocytes in response to endotoxin and IL-1 stimulation. Br J Haematol 1991;79: 22-6.
16. Vose JM, Armitage JO. Clinical applications of hematopoietic growth factors. J Clin Oncol 1995;13:1023-35.
17. Dannaeus K, Nilsson K, Jonsson JI. Distinct actions of Flt3 ligand and stem cell factor on myeloid lineage selection and maturation of granulocytes versus macrophages. Exp Hematol 1998;26:345-52.
18. Cairo MS, Plunkett JM, Nguyen A, Schendel P, van de Ven C. Effect of interleukin-11 with and without granulocyte colony-stimulating factor on in vivo neonatal rat hematopoiesis: induction of neonatal thrombocytosis by interleukin-11 and synergistic enhancement of neutrophilia by interleukin-11 + granulocyte colony-stimulating factor. Pediatr Res 1993;34:56-61.
19. Tepler I, Elias L, Smith JW II, Hussein M, Rosen G, Chang AY, et al. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 1996;87:3607-14.
20. Gordon MS, McCaskill-Stevens WJ, Battiato LA, Loewy H, Loesch D, Breeden E, et al. A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 1996;87:3615-24.
21. Basser RL, To LB, Begley CG, Mather D, Huttner C, Cebon H, et al. Rapid hematopoietic recovery after multicycle highdose chemotherapy: enhancement of filgastim-induced progenitor-cell mobilization by recombinant human stemcell factor. J Clin Oncol 1998;16:1899-908.
22. Manegold C, Jablonowski H, Armbrecht C, Strohmeyer G, Pietsch T. Serum levels of stem cell factor are increased in asymptomatic human immunodeficiency virus-infected patients and are associated with prolonged survival. Blood 1995;86:243-9.
23. Körholz D, Banning U, Bönig H, Grewe M, Schneider M, Mauz-Körholz C, et al. The role of interleukin-10 (IL-10) in IL-15-mediated T-cell responses. Blood 1997;90:4513-21.
24. Schönbohm H, Schuler M, Kolbe K, Peschel C, Huber C, Bemb W, et al. Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia. Ann Hematol 1995;71:161-8.
25. Stute N, Santana VM, Rodman JH, Schell MJ, Ihle JN, Evans WE. Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children. Blood 1992;79:2849-54.
26. Kawano Y, Takaue Y, Saito S, Sato J, Shimizu T, Suzue T, et al. Granulocyte colony-stimulating factor (CSF), macrophage-CSF, granulocyte-macrophage-CSF, Interleukin-3, and Interleukin-6 levels in sera of children undergoing blood stem cell autografts. Blood 1993;81:856-60.
27. Ortquist A, Hedlund J, Wretlind B, Carlstrom A, Kalin M. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia. Scand J Infect Dis 1995;27:457-62.
28. Knopf HP, Otto F, Engelhardt R, Freudenberg MA, Galanos C, Herrmann F, et al. Discordant adaptation of human peritoneal macrophages to stimulation by lipopolysaccharide and the synthetic lipid analogue SDZ MRL 953. J Immunol 1994;152:287-99.
29. Chang M, Suen Y, Meng G, Buzby JS, Bussel H, Shen B, et al. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production. Blood 1996;88:3354-62.
30. Wang JC, Chen C, Lou LH, Mora M. Blood thrombopoietin, IL-6 and IL-11 levels in patients with agnogenic myeloid metaplasia. Leukemia 1997;11:1827-32.
31. Heits F, Katschinski CM, Wilmsen U, Wiedemann GJ, Jelkmann W. Serum thrombopoietin and interleukin 6 concentrations in tumour patients and response to chemotherapy-induced thrombocytopenia. Eur J Haematol 199;59:53-9.
32. Chen YM, Whang-Peng J, Chern CH, Kuo BI, Wang SY, Perng RP. The prognostic value of serum cytokine levels in patients with acute infections. Chung Hua I Hsueh Tsa Chih Teipei 1995;56:75-9.
33. Chen YM, Whang-Peng J, Liu JM, Kuo BI, Wang SY, Tsai CM, et al. Serum cytokine level fluctuations in chemotherapy-induced myelosuppression. Jpn J Clin Oncol 1996;26:18-23.
34. Kojima S, Matsuyama T, Kodera Y. Plasma levels and production of soluble stem cell factor by marrow stomal cells in patients with aplastic anaemia. Br J Haematol 1997; 99:440-6.
35. Nimer SC, Leung DH, Wolin MJ, Golde CW. Serum stem cell factor levels in patients with aplastic anemia. Int J Hematol 1994;60:185-9.
36. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24: 1-8.
37. Deichmann K, Bardutzky J, Forster J, Heinzmann A, Kueher J. Common polymorphisms in the coding part of the IL-4-receptor gene. Biochem Biophys Res Commun 1997; 231:696-7.